Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-15
DOI
10.1038/s41598-017-18186-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma
- (2016) Sara Correia Marques et al. EXPERIMENTAL HEMATOLOGY
- Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation
- (2016) Nicola Amodio et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Plasma cell maturity as a predictor of prognosis in multiple myeloma
- (2016) Noriyoshi Iriyama et al. MEDICAL ONCOLOGY
- Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
- (2016) Nicola Amodio et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment
- (2016) Lavinia Raimondi et al. Biomed Research International
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- Caspase-mediated crosstalk between autophagy and apoptosis: Mutual adjustment or matter of dominance
- (2015) ShrawanKumar Singh et al. Journal of Cancer Research and Therapeutics
- Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
- (2015) E Morelli et al. LEUKEMIA
- MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
- (2014) Marco Rossi et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Sirtuin inhibitors as anticancer agents
- (2014) Jing Hu et al. Future Medicinal Chemistry
- A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells
- (2014) Marzia Leotta et al. JOURNAL OF CELLULAR PHYSIOLOGY
- In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
- (2014) Maria Teresa Di Martino et al. PLoS One
- MicroRNA: Important Player in the Pathobiology of Multiple Myeloma
- (2014) Chonglei Bi et al. Biomed Research International
- Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
- (2014) Immacolata Scognamiglio et al. Biomed Research International
- Therapeutic Aptamers March On
- (2014) Marc S Weinberg Molecular Therapy-Nucleic Acids
- Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
- (2013) E. Leone et al. CLINICAL CANCER RESEARCH
- From Target Therapy to miRNA Therapeutics of Human Multiple Myeloma: Theoretical and Technological Issues in the Evolving Scenario
- (2013) Marco Rossi et al. CURRENT DRUG TARGETS
- Emerging pathways as individualized therapeutic target of multiple myeloma
- (2013) Gabriella Misso et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Stain-Free technology as a normalization tool in Western blot analysis
- (2012) Anne Gürtler et al. ANALYTICAL BIOCHEMISTRY
- microRNA-34a Sensitizes Lung Cancer Cell Lines to DDP Treatment Independent of p53 Status
- (2012) Xi Wang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- MicroRNAs in the Pathobiology of Multiple Myeloma
- (2012) Marta Lionetti et al. CURRENT CANCER DRUG TARGETS
- Molecular Targets for the Treatment of Multiple Myeloma
- (2012) Marco Rossi et al. CURRENT CANCER DRUG TARGETS
- Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
- (2012) P. Tagliaferri et al. CURRENT CANCER DRUG TARGETS
- Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells
- (2011) Dharminder Chauhan et al. BRITISH JOURNAL OF HAEMATOLOGY
- MiR-34, SIRT1, and p53: The feedback loop
- (2011) Munekazu Yamakuchi et al. CELL CYCLE
- MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
- (2011) Ruth L. Vinall et al. INTERNATIONAL JOURNAL OF CANCER
- Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
- (2011) Michele Cea et al. PLoS One
- Combining Targeted Therapies: Practical Issues to Consider at the Bench and Bedside
- (2010) J. Rodon et al. ONCOLOGIST
- The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
- (2009) Raphael Kopan et al. CELL
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started